Innovative Therapeutics in Oncology and Neuroscience

2 Therapeutic-Area-Focused Organization Drives Leadership and Leverage Marketed / Late- Stage Products Unlock Synergies with Additional Pipeline Assets to Launch WOMEN'S CANCER GI CANCER Once-daily oral Zejula niraparib capsules 100 mg QINLOCK® (ripretinib) 50 mg tablets LUNG CANCER AUGTYRO (repotrectinib) NEUROLOGY VÝVGART (efgartigimod alfa-fcab) (gMG) Ⓡ Pipeline Shared Function tivdak Repotrectinib¹ TA-Driven Sales Force2 Bemarituzumab Adagrasib KarXT Adagrasib TTFields Zipalertinib TTFields (ADP) Efgartigim od (CIDP) TA-Driven Marketing Government Affairs, Market Access and Distribution Commercial Strategy Excellence Oncology Shared Sales (Emerging Market)² TA-Driven Medical Affairs NSAID Shared Sales (Emerging Market)² 12 Abbreviations: Therapeutic area (TA), neuroscience, autoimmune and infectious diseases (NSAID), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), generalized myasthenia gravis (gMG), Alzheimer's disease psychosis (ADP). Notes: The trademarks and registered trademarks within are the property of their respective owners. (1) NTRK+ breast cancer; (2) Core market (top hospitals in large cities) will be covered by TA-driven sales force; the remaining hospitals are emerging market covered by shared sales team. zailǝb

View entire presentation